Jacob Sullum | March 20, 2006
Tomorrow the Supreme Court will consider a case involving a diagnostic test patent that covers not just the testing method but the biological fact on which the test relies: the correlation between high levels of the amino acid homocysteine and specific vitamin deficiencies. Among other head-scratchers, the case raises the question of whether a doctor can violate the patent simply by performing a homocysteine test and thinking about its nutritional relevance. In yesterday's New York Times, Michael Crichton mocked the patent as an example of intellectual property overreach.
Help Reason celebrate its next 40 years. Donate Now!
Try Reason's award-winning print edition today! Your first issue is FREE if you are not completely satisfied.
Site comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245